Remission and eular good response in 2125 patients with rheumatoid arthritis (RA) receiving TNF-blocking agents and disease-modifying antirheumatic drugs (Dmards):: Results from a longitudinal observational study.

被引：0
|
作者：
Kvien, TK
Mikkelsen, K
Nordvåg, BY
Kaufmann, C
Rodevand, E
Schrumpf, M
Mowinckel, P
机构：
[1] Diakonhjemmet Hosp, Oslo, Norway
[2] Lillehammer Hosp Rheumat Dis, Lillehammer, Norway
[3] Univ Hosp No Norway, Tromso, Norway
[4] Buskerud Cent Hosp, Drammen, Norway
[5] St Olav Hosp, Trondheim, Norway
来源：
ARTHRITIS AND RHEUMATISM | 2004年 / 50卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S394 / S394
页数：1
相关论文
共 50 条
  • [31] TNF-blocking agents provide improvement in SF-6D utility scores in patients with rheumatoid arthritis (RA), across different levels of baseline disease activity (DAS-28):: Results from a longitudinal observational study
    Heiberg, M. S.
    Redevand, E.
    Mikkelsen, K.
    Kaufmann, C.
    Nordvag, B. Y.
    Mowinckel, P.
    Kvien, T. K.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 320 - 321
  • [32] Clinical predictors of inadequate response to conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) including methotrexate (MTX) in untreated rheumatoid arthritis patients: A single-center observational study.
    Aramaki, Toshiyuki
    Ueki, Yukitaka
    Kojima, Kanako
    Kurushima, Shota
    Tsuji, Yoshika
    Kawachi, Natsumi
    Iwamoto, Naoki
    Ichinose, Kunihiro
    Terada, Kaoru
    Eguchi, Katsumi
    Kawakami, Atsushi
    MODERN RHEUMATOLOGY, 2020, 30 (01) : 50 - 57
  • [33] Step-up combination versus switching of non-biological disease-modifying antirheumatic drugs in rheumatoid arthritis: results from a retrospective observational study
    Schoels, M.
    Kapral, T.
    Stamm, T.
    Smolen, J. S.
    Aletaha, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (08) : 1059 - 1065
  • [34] Register-based observational study of associations between inflammatory remission, formal treatment targets and the use of disease-modifying antirheumatic drugs among patients with early rheumatoid arthritis
    Lindqvist, Joakim
    Askling, Johan
    Lampa, Jon
    RMD OPEN, 2023, 9 (04):
  • [35] Latent and active tuberculosis development in patients with rheumatoid arthritis receiving biologic disease-modifying antirheumatic drugs: A single-center prospective study
    Hai, Binh Bui
    Anh, Tuan Le
    Thu, Phuong Nguyen Thi
    Van, Hung Nguyen
    Van, Giap Vu
    Van, Dung Hoang
    PLOS ONE, 2024, 19 (01):
  • [36] Switching From Immediate Release (IR) Prednisone To Delayed Release (DR) Prednisone Improves Patient Reported Outcomes In Rheumatoid Arthritis (RA) Patients On Conventional Disease-Modifying Antirheumatic Drugs (DMARDs)
    Alten, Rieke
    Holt, Robert
    Grahn, Amy
    Rice, Patricia
    Kent, Jeffery
    Buttgereit, Frank
    Gibofsky, Allan
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S963 - S964
  • [37] Safety and patient-reported outcomes through 2 years of treatment with abatacept in rheumatoid arthritis patients receiving background disease-modifying antirheumatic drugs (DMARDS): The assure trial
    Weinblatt, M. E.
    Keystone, E.
    Combe, B.
    Birbara, C.
    JOURNAL OF RHEUMATOLOGY, 2007, 34 (07) : 1631 - 1631
  • [38] Efficacy of tocilizumab in patients with moderate to severe active rheumatoid arthritis and a previous inadequate response to disease-modifying antirheumatic drugs: the ROSE study
    Yazici, Yusuf
    Curtis, Jeffrey R.
    Ince, Akgun
    Baraf, Herbert
    Malamet, Raymond L.
    Teng, Lichen L.
    Kavanaugh, Arthur
    ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (02) : 198 - 205
  • [39] Association of Seropositivity and Mortality in Rheumatoid Arthritis and the Impact of Treatment With Disease-Modifying Antirheumatic Drugs: Results From a Real-World Study
    Alemao, Evo B.
    Bao, Ying
    Weinblatt, Michael E.
    Shadick, Nancy
    ARTHRITIS CARE & RESEARCH, 2020, 72 (02) : 176 - 183
  • [40] COMPARATIVE EFFICACY OF NOVEL DISEASE-MODIFYING ANTIRHEUMATIC DRUGS AS MONOTHERAPY AND IN COMBINATION WITH METHOTREXATE IN RHEUMATOID ARTHRITIS PATIENTS WITH AN INADEQUATE RESPONSE TO TRADITIONAL DMARDS: A NETWORK META-ANALYSIS
    Buckley, Felicity
    Finckh, Axel
    Huizinga, Tom W. J.
    Dejonckheere, Fred
    Jansen, Jeroen P.
    RHEUMATOLOGY, 2014, 53 : 88 - 89
12345